Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 230
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT05813561 | The Efficacy and Safety of DWP14012 in Chinese Patients With Reflux Esophagitis | ||
| NCT04341428 | Study to Evaluate the Efficacy and Safety of DWP14012 on Maintaining Healing in Subjects With Healed Erosive Esophagitis | ||
| NCT06025409 | Evaluate the Efficacy and Safety of DWJ108J | ||
| NCT05226533 | Clinical Trials to Assess Safety and Efficacy of DWRX2003 Combination With Remdesivir in Moderate to Severe COVID-19 Patients. | ||
| NCT05868967 | A Clinical Study to Investigate the Mass Balance and Biotransformation of [14C]DWP14012 in Healthy Chinese Male Subjects | ||
| NCT04535856 | Therapeutic Study to Evaluate the Safety and Efficacy of DW-MSC in COVID-19 Patients | ||
| NCT03224117 | Clinicial Trial to Evaluate the Efficacy and Safety of DWJ211 in Patient With Moderate or Severe Submental Fat | ||
| NCT04477369 | Safety and Pharmacokinetics of DWJ1439, DWJ1464, DWC202003 or DWC202004 in Healthy Volunteers | ||
| NCT05660135 | Reduction Efficacy of OLOMAX for Blood Pressure and Low-density Lipoprotein Cholesterol in Hypertensive Patients With Dyslipidemia | ||
| NCT02069717 | Observational Study to Assess the Incidence Rate of the Major Adverse Cardiovascular Events (MACE) and Safety of Fenofibrate (Lipilfen Capsule) | ||
| NCT05378360 | DWP708 for Treating Epidermal Growth Factor Receptor Inhibitor Related Skin Toxicities | ||
| NCT03517319 | Dose-response Relationship of Botullinum Toxin (DWP 450) for Finger Flexor Spasticity | ||
| NCT03846453 | A Study to Assess Efficacy and Safety of HL036 in Subjects With Dry Eyes | ||
| NCT04782505 | Safety and Pharmacokinetics Evaluation Study According to the Dose of Camostat Mesylate in Healthy Volunteers | ||
| NCT03024086 | Efficacy and Safety of DWJ1252 in the Treatment of Functional Dyspepsia | ||
| NCT01629875 | Efficacy and Safety of DWP450 Compared With Botox in Moderate to Severe Glabellar Line | ||
| NCT03574415 | Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP14012 After Oral Administration in Healthy Japanese, Caucasian and Korean | ||
| NCT03016520 | Pharmacokinetics and Safety Study of DWJ1392 and DWC20164 in Healthy Male Volunteers | ||
| NCT04278391 | Pharmacokinetics and Safety Between "DWJ1421" and "DWC201903" in Healthy Male Volunteers | ||
| NCT02622685 | A Multiple Dose Study of DWP10292 and UDCA in Healthy Male Subjects | ||
| NCT02757144 | Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP14012 After Oral Administration in Healthy Male Volunteers | ||
| NCT03946592 | Evaluate the Efficacy and Safety of DWJ211 in Patient With Moderate or Severe Submental Fat | ||
| NCT06606093 | Evaluate the Efficacy and Safety of DWP16001 in Type 2 Diabetic Nephropathy with Moderate Renal Impairment Patients | ||
| NCT05889026 | The Effect of Extracorporeal Shock Wave Therapy After Botulinum Toxin Type A Injection for Post-stroke Spasticity | ||
| NCT03574285 | A Single-dose, Comparative Bioavailability Study of Two Formulations of Sarpogrelate HCl 300mg Tablets Under Feeding Conditions | ||
| NCT05465668 | Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic Characteristics of DWP16001 Drug A and C | ||
| NCT05466643 | A Study to Investigate the Effect of DWP16001 as add-on Therapy to Drug A in Patients With Type 2 Diabetes Mellitus | ||
| NCT05414591 | Pharmacokinetics and Safety Following Administration of DWP16001 | ||
| NCT05845489 | Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis- CloPidogREl for Primary preVENTION (HOST-PREVENTION) | ||
| NCT01397240 | The Safety and Efficacy of Albis®: The Prevention of Aspirin-induced Gastrointestinal Ulcers in Patients | ||
| NCT04221399 | Type 2 Diabetes Patients With Renal Impairment | ||
| NCT01764295 | Clinical Study for Patients With Hypertension Associated With Dyslipidemia | ||
| NCT04888728 | To Evaluate Drug-drug Interactions Between DWN12088 and Nebivolol or Paroxetine in Healthy Volunteers | ||
| NCT06000657 | Efficacy and Safety of Switching to Vemliver From Entecavir in Chronic Hepatitis B Patients Previously Treated With Entecavir | ||
| NCT07260851 | Bioequivalence Study for the Safety and the Pharmacokinetics of DWJ1622, DWC202313, and DWC202314 in Healthy Volunteers Under Fasting Conditions | ||
| NCT01636401 | Efficacy and Safety of 400 μg Twice Daily of Aclidinium Bromide vs. Placebo When Administered to Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) | ||
| NCT06508645 | Study to Evaluate the Safety/Tolerability, PK and PD After Intravenous DWJ1521 Administration in Healthy Volunteers | ||
| NCT03184402 | Efficacy and Safety of DWJ1252 in the Treatment of Functional Dyspepsia (PART 2) | ||
| NCT05832697 | An Exploratory Clinical Trial to Evaluate and Compare Safety and Pharmacokinetic Characteristics After Administration of the DWJ1439, DWJ1464, DWC202108 or DWC202109 in Healthy Adult Volunteers | ||
| NCT01635686 | Comparison the Safety and Pharmacokinetic Characteristics of DWP422 25 mg With Those of ENBREL 25MG PFS INJ. After Subcutaneous Injection in Healthy Male Volunteers | ||
| NCT04521296 | Efficacy and Safety of DWJ1248 in Patients With Mild to Moderate COVID-19 Compared to the Placebo | ||
| NCT03016494 | Safety and Pharmacokinetics Study of Fixed Dose Combination of DWJ1386 Compared With Co-administration of DWC20155 and DWC20156 in Healthy Subjects | ||
| NCT05304845 | Drug-drug Interactions Between DWP14012 and Aspirin in Healthy Subjects | ||
| NCT03009487 | A Clinical Trial to Evaluate the Efficacy and Safety of Olmesartan/Amlodipine/Rosuvastatin Combination Treatment in Patients With Concomitant Hypertension and Hyperlipidemia | ||
| NCT01094834 | A Multiple Dose Study of DWP05195 in Healthy Adult Subjects | ||
| NCT07619833 | To Evaluate the Efficacy and Safety of Initial Combination Therapy With DWP16001 and DWC202518 Compared to DWP16001 Monotherapy and DWC202518 Monotherapy in Patients With Type 2 Diabetes Mellitus | ||
| NCT05607589 | The Safety, Tolerability, PK, and PD of DWP213388 After SAD and MAD Administration in Healthy Adult Subjects | ||
| NCT03736369 | Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Erosive Gastroesophageal Reflux Disease (Phase 3) | ||
| NCT04632862 | The Efficacy and Safety of DWP16001 Compared to Placebo in the Treatment of Type 2 Diabetes Mellitus. | ||
| NCT03184415 | Efficacy and Safety of DWC20155/DWC20156 Combination Therapy in Patients With Gastritis |
